Given that a key focus of our study was to determine the impact in the bone metastatic environment, the bone metastatic PC-3 cell line, which is also not androgen responsive (a feature of advanced PCa) and readily forms tumors in vivo, was selected and modified to over-express KLK4. The gene discussed is KLK4; the disease is posterior cortical atrophy.